Thu, 23/01/2020 - 07:00
Proposals feature a soft robotic heart, a cure for genetic heart disease, a heart attack vaccine and next generation health tech
Wed, 09/10/2019 - 07:00
Belfast, UK, 9th October 2019 / Sciad Newswire / Examen, a world leader in male fertility testing, is please
Thu, 24/01/2019 - 13:00
Call for the world’s greatest minds to tackle the world’s biggest killers  The British Heart Foundation’s Big Beat Challenge is now accepting proposals
Tue, 27/11/2018 - 08:30
Prostate cancer is the most common cancer in men, with 1 in 8 diagnosed at some point in their lives.1 Indeed, with Men’s Health Awareness Month underway, the importance of tackling this prevalent diseas
Health Investor awards
Fri, 15/06/2018 - 08:30
London, UK, 15th June 2018 / Sciad Newswire / Check4Cancer is delighted to announce it has been awarded ‘Diagnostics p
Wed, 06/12/2017 - 08:00
Cambridge, UK, 6th December 2017 / Sciad Newswire / Domainex Ltd, a privately-owned drug discovery services company, is p
Thu, 26/10/2017 - 07:30
London, UK, 26th October 2017 / Sciad Newswire / This year’s Pharma Integrates conference in London, 15th-16th Nove
Tue, 26/09/2017 - 00:15
New approach informed by government priorities, consultancy with industry and the NHS, and a century of expertise
Thu, 29/06/2017 - 07:30
Australian immuno-oncology company Minomic International Ltd is proceeding to the second stage of its pioneering MILGa clinical trial of MiltuximabTM, a chimeric version of Minomic’s MIL-38 anti-Glypican1 antibody conjugated to the radioactive isotope 67Gallium.
Fri, 30/09/2016 - 10:12
ProAxsis Limited is pleased to announce that it has successfully registered a CE Mark for its novel ProteaseTag® Active Neutrophil Elastase Immunoassay.